Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This study was specifically designed to provide additional information on the mechanism of
action of direct renin inhibition postulating the higher-level RAS cascade inhibition. The
purpose of this study was to compare the prolonged efficacy and safety of aliskiren to that
of telmisartan in mild to moderate hypertensive patients in the 24 hrs Ambulatory Blood
Pressure Monitoring setting after a one week treatment withdrawal.